1. Jang, S. H., Wientjes, M.G., Lu, D., and Au, J.L. Drug delivery and transport to solid tumors. Pharmaceutical Res., 20 (9):1337-50, 2003.
2. Lu, Ze, Yeh, T.K., Tsai, M., Au, J.L.-S., and Wientjes, M.G. Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy. Clin. Cancer Res., 10:7677-84, 2004.
3. Yeh, T.K., Lu, Z., Au, J.L.-S. and Wientjes, M.G. Formulating paclitaxel in nanoparticles alters its disposition. Pharmaceutical Res., 22: 867-874, 2005.
4. Lu, Z., Wientjes, T.S. and Au, J.L.-S. Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors. Pharmaceutical Res., 22: 1069-1078, 2005.
5. Xin, Y., Lyness, G., Chen, D., Song, S., Wientjes, M.G., and Au, J.L. Low dose suramin as a chemosensitizer of bladder cancer to mmc. J. Urol., 174:322-7, 2005.
6. Wang, J., Lu, Z., and Au, J.L.-S. Protection against chemotherapy-induced alopecia. Pharmaceutical Res., 23 (11): 2505-2514, 2006.
7. Tsai, M., Lu, Z., Wang, J., Yeh, T.-K., Wientjes, M.G., and Au, J.L.-S. Effects of carrier on disposition and antitumor activity of intraperitoneal paclitaxel. Pharmaceutical Res., 24 (9): 1691-1701, 2007.
8. Lu, D., Wientjes, M.G., Lu, Z., and Au, J.L-S. Tumor Priming Enhances Delivery and Efficacy of Nanomedicines, J. Pharmacol. Exp. Ther., 322(1):80-8, 2007.
9. Lu, Z., Tsai, M., Lu, D., Wang, J., Wientjes, M.G., and Au, J.L.-S. Tumor penetrating microparticles for intraperitoneal therapy of ovarian cancer. J. Pharmacol. Exp. Ther., 327(3):673-682, 2008.
10. Wang, J., Lu, Z., Wientjes, M.G., and Au, J.L.-S. Delivery of siRNA Therapeutics: Barriers and Carriers. AAPS J., 12:492-503, 2010.
11. Lu, Z., Wang, J., Wientjes, M.G., and Au, J.L-S. Intraperitoneal therapy for peritoneal cancer. Future Oncology, 6:1625-41, 2010. 12. Au, J.L. and Wientjes, M.G. Combination intravesical hyperthermia and chemotherapy for bladder cancer. Oncology (Williston. Park), 24:1155-1160, 2010.
13. Lu, Z., Yeh, T.K., Wang, J., Chen, L., Lyness, G., Xin, Y., Wientjes, M.G., Bergdall, V., Couto, G., Alvarez-Berger, F., Kosarek, C.E., and Au, J.L-S. Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy. J. Urol., 185:1478-1483, 2011.
14. Li, Y., Wang, J., Wientjes, M.G., and Au, J.L-S. Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor. Adv. Drug Deliv. Rev., 64:29-39, 2012.
15. Wong, H.L., Shen, Z., Lu, Z., Wientjes, M.G., and Au, J.L-S. Paclitaxel tumor-priming enhances siRNA delivery and transfection in 3-dimensional tumor cultures. Mol. Pharm., 8:833-840, 2011. PMCID: PMC3109178
16. Li, Y., Wang, J., Gao, Y., Zhu, J., Wientjes, M.G., Au, J.L-S. Relationships between Liposome Properties, Cell Membrane Binding, Intracellular Processing, and Intracellular Bioavailability. AAPS J. 13:585-597, 2011. PMCID: PMC3231863
17. Wang, J., Lu, Z., Gao, Y., Wientjes, M.G., Au, J.L.-S. Improving delivery and efficacy of nanomedicines in solid tumors: Role of tumor priming. Nanomedicine (Lond). 6:1605-1620, 2011. PMCID: PMC3655409
18. Gao, Y., Li, M., Chen, B., Shen, Z., Guo, P., Wientjes, M.G., and Au, J.L. Predictive models of diffusive nanoparticle transport in 3-dimensional tumor cell spheroids. AAPS J., 2013.
19. Wang J, Lu Z, Yeung BZ, Wientjes MG, Cole DJ, Au JL. Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors. J Control Release. 178:79-85, 2014. PMCID: PMC3994124.
20. Wang J, Lu Z, Wang J, Cui M, Yeung BZ, Cole DJ, Wientjes MG, Au JL. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors. J Control Release. 216:103-10, 2015. PMCID: PMC4582943.